Company intelligence / Profile preview

CYTO365

Höganäs, Skåne, Swedencyto365.com ↗

Ownership: Private
Development stage: Commercial

Overview

CYTO365 has developed and commercialized the RondelO™ multi-inlet turn valve manifold, a patented device designed to prevent mixing of drugs during IV infusion. The system enables sequential drug delivery with flushing between administrations, improving patient safety and workflow efficiency. The company holds over 100 patents globally and has achieved CE Mark approval under MDR regulations. Products are being distributed in the US, Brazil, several European countries, Taiwan, and Nordic countries.

Therapeutic areas: OtherOncology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Distribution partners in the USDistribution partners in BrazilDistribution partners in NetherlandsDistribution partners in ItalyDistribution partners in SpainDistribution partners in AustriaDistribution partners in Nordic countriesDistribution partners in Taiwan

Beyond the preview

Go deeper on CYTO365.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CYTO365.